Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$460,899,675
+$81,678,393 QoQ
Shares Held
1,814,780
+17.0% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#112
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JONES FINANCIAL COMPANIES LLLP holds $2,915,385,555 across 19 Drug Manufacturers - General names. JNJ ranks #2 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
746,099 | $894,893,598 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,814,780 | $460,899,675 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,548,737 | $327,512,704 | |
| 4 | AZN |
Astrazeneca PLC
|
1,670,876 | $316,831,506 | |
| 5 | NVS |
Novartis AG
|
1,974,043 | $309,372,018 | |
| 6 | ABBV |
AbbVie Inc.
|
988,813 | $248,824,903 | |
| 7 | PFE |
Pfizer Inc
|
4,638,683 | $111,699,485 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
502,809 | $63,524,888 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $460,899,675 | 1,814,780 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $379,221,282 | 1,551,388 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $169,545,855 | 819,260 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $138,147,540 | 745,052 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $101,558,892 | 664,870 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $92,800,249 | 559,577 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $66,054,750 | 456,747 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $56,712,085 | 349,945 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $32,036,225 | 219,186 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $21,013,167 | 132,835 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $17,820,397 | 113,694 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $17,043,722 | 109,430 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $18,630,765 | 112,559 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $17,614,045 | 113,639 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $20,463,136 | 115,840 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,816,948 | 115,187 | Shares | Defined | 2022-11-03 | |
| 2022-06-30 | $20,881,388 | 117,635 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $21,582,182 | 121,775 | Shares | Defined | 2022-05-02 | |
| 2021-12-31 | $21,295,135 | 124,482 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $19,730,293 | 122,169 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $20,462,355 | 124,210 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $20,554,596 | 125,066 | Shares | Defined | 2021-04-30 | |
| 2020-12-31 | $19,207,913 | 122,048 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $17,610,419 | 118,286 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $16,138,558 | 114,759 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $15,086,374 | 115,049 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||